146 related articles for article (PubMed ID: 38697157)
1. Olanzapine for chemotherapy-induced nausea and vomiting control.
Radhakrishnan V; Seshadri RA; Nair S
Lancet Oncol; 2024 May; 25(5):e174. PubMed ID: 38697157
[No Abstract] [Full Text] [Related]
2. Olanzapine for chemotherapy-induced nausea and vomiting control.
Tsuruta S; Matsuguma K; Kawasaki N; Ishikawa A; Ishiki H
Lancet Oncol; 2024 May; 25(5):e176. PubMed ID: 38697159
[No Abstract] [Full Text] [Related]
3. Olanzapine for chemotherapy-induced nausea and vomiting control.
Sharma V; Dadheech A; Yadav A; Pehalajani JK; Somani N
Lancet Oncol; 2024 May; 25(5):e175. PubMed ID: 38697158
[No Abstract] [Full Text] [Related]
4. Olanzapine for chemotherapy-induced nausea and vomiting control - Authors' reply.
Bajpai J; Pawar A; Kapu V; Prabhash K
Lancet Oncol; 2024 May; 25(5):e177. PubMed ID: 38697160
[No Abstract] [Full Text] [Related]
5. Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis.
Chow R; Navari RM; Terry B; DeAngelis C; Prsic EH
Support Care Cancer; 2022 Feb; 30(2):1015-1018. PubMed ID: 34613472
[No Abstract] [Full Text] [Related]
6. Olanzapine for nausea and vomiting.
Licup N
Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine: is it enough for CINV prevention?
Tienchaiananda P; Nipondhkit W; Prasongsook N
Ann Palliat Med; 2020 Jul; 9(4):2427-2429. PubMed ID: 32434367
[No Abstract] [Full Text] [Related]
8. A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Wang XF; Feng Y; Chen Y; Gao BL; Han BH
Sci Rep; 2014 Apr; 4():4813. PubMed ID: 24770591
[TBL] [Abstract][Full Text] [Related]
9. In Reply: Olanzapine for Chemotherapy-induced Nausea and Vomiting Pediatric Population: Take Home Message?
Meena JP; Gupta AK; Jat KR
J Pediatr Hematol Oncol; 2024 May; 46(4):216. PubMed ID: 38456612
[No Abstract] [Full Text] [Related]
10. Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.
DeRemer DL; Clemmons AB; Orr J; Clark SM; Gandhi AS
Pharmacotherapy; 2016 Feb; 36(2):218-29. PubMed ID: 26890915
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.
Chow R; Chiu L; Navari R; Passik S; Chiu N; Popovic M; Lam H; Pasetka M; Chow E; DeAngelis C
Support Care Cancer; 2016 Feb; 24(2):1001-1008. PubMed ID: 26530228
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Olanzapine for Symptom Relief in Cancer Patients.
Nakagawa N; Suzuki M
J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):216-222. PubMed ID: 36250742
[TBL] [Abstract][Full Text] [Related]
13. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
14. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
Bosnjak SM; Dimitrijevic J; Djordjevic F
Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5-mg dose of olanzapine for breakthrough nausea and vomiting in patients receiving carboplatin-based chemotherapy: a prospective trial.
Maeda A; Yoshida H; Inoue H; Ejiri M; Yamaguchi S; Kushihara H; Yamamoto Y; Ando Y; Sato Y; Tashiro Y; Hasegawa A; Takahara Y; Mizutani M; Oze I; Shimizu J
Ann Palliat Med; 2021 Mar; 10(3):2699-2708. PubMed ID: 33615803
[TBL] [Abstract][Full Text] [Related]
16. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
Fonte C; Fatigoni S; Roila F
Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
Navari RM; Qin R; Ruddy KJ; Liu H; Powell SF; Bajaj M; Dietrich L; Biggs D; Lafky JM; Loprinzi CL
N Engl J Med; 2016 Jul; 375(2):134-42. PubMed ID: 27410922
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.
Yoodee J; Permsuwan U; Nimworapan M
Crit Rev Oncol Hematol; 2017 Apr; 112():113-125. PubMed ID: 28325253
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity.
Vig S; Seibert L; Green MR
J Cancer Res Clin Oncol; 2014 Jan; 140(1):77-82. PubMed ID: 24173694
[TBL] [Abstract][Full Text] [Related]
20. Re: "Olanzapine for Nonchemotherapy Related Nausea and Emesis in Patients With a Palliative Care Consult".
Lowry MF
J Pain Symptom Manage; 2024 Jan; 67(1):e113. PubMed ID: 37611880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
